News & Updates
Filter by Specialty:
More evidence support ticagrelor monotherapy after <1-month DAPT in ACS
Dropping aspirin after <1 month of dual antiplatelet therapy (DAPT) with ticagrelor is superior to continuing both drugs through 12 months in patients with acute coronary syndrome (ACS) implanted with drug-eluting stents in the T-PASS trial.
More evidence support ticagrelor monotherapy after <1-month DAPT in ACS
22 Nov 2023
Secondary hypertension prevalent in hypertensive children, especially girls
A recent study in China has found that secondary hypertension is still the most common type of hypertension among children, particularly in girls, during the past decade. The dominant cause of this condition is renal diseases, followed by rheumatic immune diseases.
Secondary hypertension prevalent in hypertensive children, especially girls
19 Nov 2023
Healthy lifestyle helps prevent CHD despite genetic susceptibility to obesity
People with high or medium genetic risk of abdominal obesity but who have a healthy lifestyle are less likely to develop coronary heart disease (CHD) than those with low genetic risk and an unhealthy lifestyle, a study has shown.
Healthy lifestyle helps prevent CHD despite genetic susceptibility to obesity
19 Nov 2023
6-month resistance training eases platelet activation in hypertensive women
Resistance training is effective in reducing platelet aggregation by modulating the purinergic system in hypertensive women, suggests a recent study, which shows an association between purinergic signaling and platelet activation in hypertension.
